Search
Dec 18, 2023
Using a covalent menin inhibitor as an approach against diabetes (and more) with Biomea Fusion's CEO
Thomas Butler describes Biomea's hypothesis of utilizing a covalent, irreversible menin inhibitor to promote beta cell proliferation.